In this Your Health segment, Paul Fishman, MD, PhD, discusses a new medication to treat Alzheimer's disease, Leqembi (lecanemab-irmb), recently approved by the U.S. Food and Drug Administration. Dr. Fishman is a neurologist at the University of Maryland Medical Center and a professor of neurology at the University of Maryland School of Medicine.
For more information call 410-328-4323
Learn more:
[ Ссылка ]
